Results 111 to 120 of about 1,394 (181)

Unmet Clinical Needs in the Management of Idiopathic Multicentric Castleman Disease: A Consensus-based Position Paper From an ad hoc Expert Panel

, 2023
Pier Luigi Zinzani, Marco Paulli, Luca Arcaini, Emanuel Della‐Torre, Simone Ferrero, Amalia Figuera, Ferdinando Frigeri, Maurizio Martelli, Elena Sabattini, Riccardo Scarpa, Giovanni Barosi   +10 more
openalex   +1 more source

Use of tocilizumab to treat IgA nephropathy complicated by idiopathic multicentric Castleman disease: a case report. [PDF]

BMC Nephrol
Komeno Y, Usui T, Inoue K, Nakajima K, Harada T, Shimizu T, Tsunoda R, Morito N, Mase K, Usui J, Saito C, Kawanishi K, Yamagata K.   +12 more
europepmc   +1 more source

Membranous nephropathy with thrombotic microangiopathy-like lesions successfully treated with tocilizumab in a patient with idiopathic multicentric Castleman disease

, 2021
Takeshi Tosaki, Masahiro Okabe, Tomo Suzuki, Akihiro Shimizu, Kentaro Koike, Nobuo Tsuboi, Tetsuya Kawamura, Ryuji Ohashi, Shingo Yano, Takashi Yokoo   +9 more
openalex   +2 more sources

A patient-derived CABIN1 mutation recapitulates features of idiopathic multicentric Castleman disease in a mouse model. [PDF]

Blood Adv
Laczko D, Tsao P, Pai RA, Zinski J, Gonzalez MV, Mumau MD, Raabe T, Muramatsu H, Pardi N, Kambayashi T, Fajgenbaum DC.   +10 more
europepmc   +1 more source

Aseptic Meningitis-retention Syndrome Associated with Tocilizumab in a Patient with Idiopathic Multicentric Castleman Disease

, 2021
Akira Arakawa, Masaki Iizuka, Shuichi Matsuda, Erika Matsubara, Hiroki Yamazaki, Noritada Yoshikawa, Hirotoshi Tanaka, Toshihiro Yoshizawa   +7 more
openalex   +2 more sources

Idiopathic multicentric Castleman disease resembling autoimmune diseases: A case report. [PDF]

Medicine (Baltimore)
Li T, Yao M, Hou Y.
europepmc   +1 more source

Morphological and quantitative CT features of anterior mediastinal lesions in TAFRO syndrome and idiopathic multicentric Castleman disease. [PDF]

Front Immunol
Mohamed L, Umeda M, Tsutsui S, Toya R, Umetsu A, Otsuka M, Endo Y, Shimizu T, Fukui S, Sumiyoshi R, Kawakami A, Koga T.   +11 more
europepmc   +1 more source

Immune‐mediated thrombocytopenia and IL‐6‐mediated thrombocytosis observed in idiopathic multicentric Castleman disease [PDF]

Ayelet Rubenstein, Sheila K. Pierson, Saishravan Shyamsundar, Mateo Sarmiento Bustamante, Michael V. Gonzalez, Ira D. Milller, Joshua D. Brandstadter, Melanie Mumau, David C. Fajgenbaum   +8 more
openalex   +1 more source

Reversible cerebral vasoconstriction syndrome in idiopathic multicentric Castleman disease under treatment with tocilizumab. [PDF]

BMJ Neurol Open
Kamimura N, Ueda N, Kimura K, Nishikori A, Sato Y, Kishida H, Tanaka F.   +6 more
europepmc   +1 more source

A Placebo-Controlled Exploratory Trial of Sirolimus for Tocilizumab-Resistant Idiopathic Multicentric Castleman Disease: Early Termination and Long-Term Extension Results Based on Descriptive Results From Two Patients. [PDF]

Cureus
Koga T, Sumiyoshi R, Shimizu T, Hosogaya N, Fukushima C, Yamamoto H, Yoshifuji H, Higa S, Kawakami A.   +8 more
europepmc   +1 more source